Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease.

作者信息

Heidenreich A, Sesterhenn I A, Moul J W

出版信息

Cancer. 1997 May 1;79(9):1641-5; discussion 1646. doi: 10.1002/(sici)1097-0142(19970501)79:9<1641::aid-cncr1>3.0.co;2-f.

DOI:10.1002/(sici)1097-0142(19970501)79:9<1641::aid-cncr1>3.0.co;2-f

PMID:9128977

Abstract

摘要

相似文献

Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease.

Cancer. 1997 May 1;79(9):1641-5; discussion 1646. doi: 10.1002/(sici)1097-0142(19970501)79:9<1641::aid-cncr1>3.0.co;2-f.

Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease.

Cancer. 1998 Jan 1;82(1):230-2. doi: 10.1002/(sici)1097-0142(19980101)82:1<231::aid-cncr33>3.0.co;2-1.

MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis.

Cancer. 1997 May 1;79(9):1710-6.

Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors.

J Urol. 1997 Aug;158(2):620-5.

Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.

Cancer. 1995 Feb 1;75(3):844-50. doi: 10.1002/1097-0142(19950201)75:3<844::aid-cncr2820750316>3.0.co;2-c.

Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.

Cancer. 1998 Sep 1;83(5):1002-11.

Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors.

Mod Pathol. 1995 Jun;8(5):492-7.

Staging and prognostic factors in testicular cancer.

Semin Surg Oncol. 1999 Dec;17(4):223-9. doi: 10.1002/(sici)1098-2388(199912)17:4<223::aid-ssu2>3.0.co;2-p.

[Prognostic factors for extratesticular involvement in stage I testicular cancer. Apropos of 58 cases].

Bull Cancer. 1994 Apr;81(4):311-7.

Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation.

Cancer. 1993 Nov 15;72(10):3029-35. doi: 10.1002/1097-0142(19931115)72:10<3029::aid-cncr2820721027>3.0.co;2-6.

引用本文的文献

[Retroperitoneal lymphadenectomy (RPLND) for the treatment of testicular germ cell tumors-open or robotic? Pro open surgery : RPLND in the management of testis cancer].

Urologie. 2025 Sep 11. doi: 10.1007/s00120-025-02673-8.

Excellent survival in relapsed stage I testicular cancer.

BMC Cancer. 2023 Sep 15;23(1):870. doi: 10.1186/s12885-023-11388-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验